You are viewing an expired notice.

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Summary

OCID:: ocds-kuma6s-106639
Published by:: Swansea University
Authority ID:: AA0345
Publication date:: 14 December 2020
Deadline date:: 11 January 2021
Notice type:: Contract Notice
Has documents:: No
Has SPD:: No
Has Carbon Reduction Plan:: N/A

Abstract

The Cluster for Epigenomics and Antibody drug conjugate (ADC) Therapeutics (CEAT) is a GBP 2.6m project, led by the Reproductive Biology and Gynaecological Oncology (RBGO) group at Swansea University Medical School and is aimed at developing new therapeutics for the treatment of ovarian cancer. The CEAT project receives external funding from WEFO and Smart Expertise. A key output of the CEAT project is to establish a developmental pipeline for clinically acceptable monovalent ADCs. As part of this output, four distinctive protein biomarkers have been identified as primary ADC targets. The project therefore require the hybridoma development of four antibodies raised against these targets. Moreover, it is essential that we receive sequence optimisation prior to antibody production to ensure we obtain successful antibody-target compatibility. Following hybridoma development we will also require in-life antibody localisation studies to confer antibody binding is restricted to tumoral compartments of the target organ. This service is to be carried out at the supplier organisation and resulting products and research outputs are to be received by the RBGO group at Swansea University Singleton Campus. The aim is to appoint a contract to start in February 2021 with a duration of 6-9 months.

Full notice text

CONTRACT NOTICE – NATIONAL

Notice Type: SERVICES

1 Authority Details

1.1 Authority Name and Address

Official Name: Swansea University
Postal Address: Procurement , VC's Office, Swansea University, Singleton Park,
Town: Swansea	Postal Code: SA2 8PP	Country: UK
For the attention of: Sue Davies	Telephone: +44 1792295890
E-Mail:	Fax:
Internet Address (URL): www.swansea.ac.uk Electronic access to information: https://etenderwales.bravosolution.co.uk/home.html Electronic submission of tenders and requests to participate: https://etenderwales.bravosolution.co.uk/home.html

1.2 Address from which documentation may be obtained

As in 1.1

1.3 Completed documents must be returned to:

As in 1.1

2 Contract Details

2.1 Title

Tender for Antibody Sequence Optimisation Hybridoma Production and Post-development In-lif

2.2 Description of the goods or services required

A key output of the CEAT project is to establish a developmental pipeline for clinically acceptable monovalent ADCs. As part of this output, four distinctive protein biomarkers have been identified as primary ADC targets.

The project therefore require the hybridoma development of four antibodies raised against these targets. Moreover, it is essential that we receive sequence optimisation prior to antibody production to ensure we obtain successful antibody-target compatibility.

Following hybridoma development we will also require in-life antibody localisation studies to confer antibody binding is restricted to tumoral compartments of the target organ.

This service is to be carried out at the supplier organisation and resulting products and research outputs are to be received by the RBGO group at Swansea University Singleton Campus. The aim is to appoint a contract to start in February 2021 with a duration of 6-9 months.

NOTE: The authority is using eTenderwales to carry out this procurement process. To obtain further information record your interest on Sell2Wales at https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=106639

2.3 Notice Coding and Classification

a) Commodity Codes

	Code		Description
	71900000		Laboratory services
	73100000		Research and experimental development services
	73111000		Research laboratory services

b) Delivery Location/Area

	Code		Location
	1018		Swansea

2.4 Total quantity or scope of tender

Please refer to the Tender Specification provided within the ITT suite of documents, available in ITT 85113 of etenderwales BravoSolution

3 Conditions for Participation

3.1 Minimum standards and qualification required

4 Administrative Information

4.1 Type of Procedure

Single stage

4.2 Reference number attributed to the notice by the contracting authority

SU103(20)

4.3 Time Limits

Time-limit for receipt of completed tenders
15-01-2021 Time 12:00

Estimated award date
01-02-2021

4.5 Language or languages in which tenders or requests to participate can be drawn up

EN CY

4.6 Tender Submission Postbox

5 Other Information

5.1 Additional Information

Due to the sensitive nature of the project is essential that this contract be awarded to a single supplier and not split across a number of suppliers.

(WA Ref:106639)

Relates to the following project/programme financed by EU Community Funds: The CEAT project receives external funding from WEFO and Smart Expertise.

5.2 Additional Documentation

5.3 Publication date of this notice

14-12-2020

SF 51a

Coding

Commodity categories

ID	Title	Parent category
71900000	Laboratory services	Architectural, construction, engineering and inspection services
73100000	Research and experimental development services	Research and development services and related consultancy services
73111000	Research laboratory services	Research services

Delivery locations

ID	Description
1018	Swansea

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID	Description
There are no alert restrictions for this notice.

About the buyer

Main contact:: N/a
Admin contact:: N/a
Technical contact:: N/a
Other contact:: N/a

Further information

Date	Details
11/01/2021 13:37	Notice date(s) changed The Deadline date was changed from 15/01/2021 12:00 to 22/01/2021 12:00. The clarification and tender deadlines have both been extended by 1 week to allow the completion of clarifications
12/01/2021 17:23	Notice Cancelled This notice has been cancelled. The original deadline date of 22/01/2021 is no longer applicable. This tender has been closed and the process cancelled due to the requirement for a revision of the Tender Specification and Questions. Suppliers who have accessed the tender documents on etenderwales have already been informed and that itt also closed down

Tender for Antibody Sequence Optimisation Hybridoma Production and Post-development In-lif

Contents

Summary

Abstract

Full notice text

CONTRACT NOTICE – NATIONAL

1 Authority Details

1.1

Authority Name and Address

1.2

Address from which documentation may be obtained

1.3

Completed documents must be returned to:

2 Contract Details

2.1

Title

2.2

Description of the goods or services required

2.3

Notice Coding and Classification

2.4

Total quantity or scope of tender

3 Conditions for Participation

3.1

Minimum standards and qualification required

4 Administrative Information

4.1

Type of Procedure

4.2

Reference number attributed to the notice by the contracting authority

4.3

Time Limits

4.5

Language or languages in which tenders or requests to participate can be drawn up

4.6

Tender Submission Postbox